February 17, 2026 18:22 ET | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BridgeBio…
PANAMA CITY, Feb. 11, 2026 /PRNewswire/ -- In 2025, amid heightened volatility and widening dispersion across sectors, HTX delivered a…
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 10, 2026 /PRNewswire/ -- The New York…
February 06, 2026 16:01 ET | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix,…
February 06, 2026 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Feb. 06, 2026 (GLOBE NEWSWIRE)…
February 02, 2026 16:05 ET | Source: Candel Therapeutics NEEDHAM, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc.…
January 27, 2026 17:10 ET | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- In…
HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in…
PANAMA CITY, Jan. 23, 2026 /PRNewswire/ -- In 2025, persistent macro uncertainty and rapidly shifting crypto narratives turned asset selection…
January 16, 2026 16:05 ET | Source: Context Therapeutics Inc. PHILADELPHIA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc.…